looks to be confirmed...
After using propensity score matching and adjusting for potential confounders, ivermectin was associated with reduced mortality vs remdesivir (OR 0.308, 95% CI (0.198,0.479)),Risk Difference -5.224%, CI (-7.079%,-3.369%), p <0.0001.
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdr…
www.sciencedirect.com
in other words, 70 percent less chance of dying by taking ivermectin instead of remdesivir.
and a 1 in 10,000 probability of this conclusion from random chance. But
fluvoxamine is still probably a better choice for side effects.